Condition

Gout

Compensation

Variable

Duration

Gout

Official Title

A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Patients Refractory to Conventional Therapy

Study Summary

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 21+
Inclusion History of symptomatic gout
Exclusion History of anaphylaxis or severe allergic reactions to medications
Start Date
Compensation Variable
Location Orlando, FL

Study Information

Condition Gout

Administrative Information

Study ID Pain

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
loading
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.